Translate page

CML publications

Please find below a selection of interesting articles on CML from peer-reviewed journals. Recent publications include:


Clinical CML papers
 

Scientific CML papers

More CML Publications 2026

Clinical Publications Scientific Publications
February 2026
Secondary chronic myeloid leukemia in the blast phase with mixed phenotype after radiation therapy: A Case Report
Aoki M et al. EJHaem, February 2026 
– open access publication 
ATTEC-mediated degradation of BCR-ABL in chronic myeloid leukemia cells
Wang Z et al. Eur J Med Chem, February 2026

 

Integrative multi-omics analysis of long non-coding RNA regulatory networks in chronic myeloid leukemia resistance and leukemic stem cell persistence
Soltani I et al. Comput Biol Chem, February 2026

  Asciminib and pulsed ATRA as post-remission therapy in T3151I mutated PML_RARA-positive blast crisis of chronic myeloid leukemia
Mazzarella R et al. Ann Hematol, February 2026 
– open access publication


 

Quantitative reverse transcription PCR compared with high-resolution melting for simultaneous detection and quantification of four isoforms of BCR::ABL1
Zhou T et al. J Clin Pathol, February 2026

Dual proteasome and histone deacetylase inhibition overcomes tyrosine kinase inhibitor resistance in breakpoint cluster region: Abdelson 1-driven leukaemia cell lines
Okabe S et al. J Cell Mol Med, February 2026 
– open access publication
 

January 2026
Randomized phase 3 trial of Ropeginterferon alpha-2b versus surveillance after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia (ENDURE/CML-IX)
Burchert A et al. Leukemia, January 2026
(epub ahead of print) 
– open access publication
Hsp-70 Bim interaction mediated mitophagy as a potential therapeutic target for CML stem cells
Song T et al. Stem Cell Reports, January 2026 
– open access publication
Ponatinib for CML patients in routine clinical practice: the PONDEROSA study
Schenk T et al. Ann Hematol, January 2026 
– open access publication
Enhanced detection of splice-altering variants in hematologic malignancies using targeted RNA-sequencing data
Maqsood M et al. J Mol Diagn, January 2026
 
Risk factors and reasons for switching from front-line therapy in the Italian CML network: A cohort study
Breccia M et al. Br J Haematol, January 2026
(epub ahead of print)
Identification of a Mushashi2 translocation as a novel oncogene in myeloid leukemia
Spinler K et al. Elife, January 2026 
– open access publication
 
Treatment-free remission after two nilotinib consolidation durations in chronic myeloid leukemia treated with imatinib: Phase 3 ENESTPath results
Réa D et al. Leukemia, January 2026 (epub ahead of print)
Quantitative reverse transcription PCR completed with high-resolution melting for simultaneous detection and quantification of four isoforms of BCR::ABL1
Zhou T et al. J Clin Pathol, January 2026
(epub ahead of print)
 
Management of chronic myeloid leukemia during pregnancy: Review of evidence and treatment algorithm
Haddad FG et al. Clin Lymphoma Myeloma Leuk,
January 2026
Sequential BCR::ABL1 evaluation during dose de-escalation in peripheral blood is more predictive of TFR success than single assessment at dose de-escalation in either peripheral blood or bone marrow
Patterson SD et al. Blood, January 2026
(epub ahead of print) 
– open access publication 

Real-world outcomes with low-dose dasatinib (50 mg) in imatinib-resistant chronic myeloid leukemia chronic-phase: A retrospective analysis of efficacy and safety
Gangadaran N et al. Cancer Rep (Hobokken),
January 2026 
– open access publication

Mmrn1 expression defines a novel subset of hematopoietic stem cells and leukemia stem cells with great self-renewal potential
Chen N et al. Haematologica, January 2026
(epub ahead of print) 
– open access publication
 
Evaluating the safety of combining tyrosine kinase inhibitors with anticoagulants in chronic myeloid leukemia: A systematic review
Gameil A et al. Oncology, January 2026
(epub ahead of print) 
– open access publication
 
One-year consolidation with ponatinib 15 mg in chronic myeloid leukemia on deep molecular response with imatinib
Pérez-Lamas L et al. Ann Hematol, January 2026 
– open access publication
 
Prediction of relapse after discontinuation of tyrosine kinase inhibitor treatment in chronic myeloid leukemia
Ross DM. Leuk Lymphoma, January 2026
(epub ahead of print)
 
Introduction to a How I Treat series on chronic myeloid leukemia
Gotlib J. Blood January 2026
 
How I treat advanced phases of CML
Mauro MJ. Blood, January 2026
 
How I evaluate and treat resistance and relapse in CML
Soverini S and Castagnetti F. Blood, January 2026
 
How I individualize frontline treatment for chronic phase CML
Leyte-Vidal A and Shah NP. Blood, January 2026
 
How I approach hematopoietic stem cell transplantation for CML in a TKI world
Chalandon Y et al. Blood, January 2026
 
How I manage chronic myeloid leukemia during pregnancy 
Abruzzese E, Chelysheva E. Blood January 2026
 
Advances of next-generation STAMP inhibitors in chronic myeloid leukemia
Costa A and Breccia M. Expert Opin Investig Drugs, January 2026 
 
Drug resistance in chronic myeloid leukemia: The involvement of Galectin-1 and Galectin-3
Yildirim C. Mol Biol Rep, January 2026
 
Sequential BCR::ABL1 evaluation during dose de-escalation in peripheral blood is more predictive of TFR success than single assessment at dose de-escalation in either peripheral blood or bone marrow
Patterson SD et al. Leukemia, January 2026
(epub ahead of print) 
– open access publication
 
An overview of chronic myeloid leukemia treatment:
From tyrosine kinase inhibitors to novel and emerging therapies

Sekar AJ et al. Eur J Haematol, January 2026 (epub ahead of print) 
– open access publication
 

Influence of pharmacokinetics-related polymorphisms on asciminib exposure in patients with Japanese chronic myeloid leukemia
Takahashi N et al. Eur J Clin Pharmacol, January 2026

 
Specifically targeting the ABL myristoyl pocket: STAMP inhibitors for chronic myeloid leukemia
Ureshino H and Kimura S. Expert Rev Hematol, January 2026 
(epub ahead of print)

Find publications on pediatric CML here
Find publications on COVID-19 and CML here
Find CML publications from the emerging regions here

CML Publications 2014-2025


Would you like to suggest an interesting paper or article? >> Please provide us with the details here and we will be happy to review your suggestion!

Search for more publications on CML at PubMed.gov